Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal

Bibliographic Data

ID14905545
AuthorsLéa Duchesne (0000-0001-8139-319X, Inserm, corresponding author), Gilles Hejblum (0000-0003-0127-1964, Inserm), Ndèye Coumba Toure Kane (0000-0002-4708-6329, Hôpital Aristide Le Dantec), Richard Njouom (0000-0003-3112-6370, Centre Pasteur du Cameroun), Thomas-D'aquin Toni, Thomas-d’Aquin Toni (University Hospital Medical Center at Treichville), Raoul Moh (0000-0002-1678-3340, Université Nangui Abrogoua), Babacar Sylla (Lyon 1 Université), Nicolas Rouveau (0000-0002-5621-4230, Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Alain Attia (Centre Hospitalier Universitaire de Yopougon), Karine Lacombe (0000-0001-8772-9029, Inserm)
Year2020
Volume75
Pages102613
Publication date2020-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2019.102613
PMID31786434
OpenAlexW2990194590
LanguageEN
Citations received3
References cited30

Tools

Open DOISci-HubOpen Access